Search Results - "Canino, Michele A."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Comparison of minimum inhibitory concentration results for gepotidacin obtained using agar dilution and broth microdilution methods by Arends, S.J. Ryan, Canino, Michele A., Mendes, Rodrigo, Scangarella-Oman, Nicole E., Flamm, Robert K.

    “…Gepotidacin (GSK2140944) is a first in class, novel triazaacenaphthylene bacterial type II topoisomerase inhibitor in Phase 3 clinical development for the…”
    Get full text
    Journal Article
  2. 2

    In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes by Hackel, Meredith A, Karlowsky, James A, Canino, Michele A, Sahm, Daniel F, Scangarella-Oman, Nicole E

    Published in Antimicrobial agents and chemotherapy (15-02-2022)
    “…Gepotidacin (formerly GSK2140944) is a first-in-class triazaacenaphthylene antibacterial currently in phase III clinical trials. When tested against…”
    Get full text
    Journal Article
  3. 3
  4. 4